244 related articles for article (PubMed ID: 26053587)
41. Renal medullary carcinoma: A national analysis of 159 patients.
Ezekian B; Englum B; Gilmore BF; Nag UP; Kim J; Leraas HJ; Routh JC; Rice HE; Tracy ET
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28485059
[TBL] [Abstract][Full Text] [Related]
42. Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.
Carlo MI; Chaim J; Patil S; Kemel Y; Schram AM; Woo K; Coskey D; Nanjangud GJ; Voss MH; Feldman DR; Hsieh JJ; Hakimi AA; Chen YB; Motzer RJ; Lee CH
Clin Genitourin Cancer; 2017 Dec; 15(6):e987-e994. PubMed ID: 28558987
[TBL] [Abstract][Full Text] [Related]
43. Predictive role of PD-L1 expression in the response of renal Medullary carcinoma to PD-1 inhibition.
Sodji Q; Klein K; Sravan K; Parikh J
J Immunother Cancer; 2017 Aug; 5(1):62. PubMed ID: 28807004
[TBL] [Abstract][Full Text] [Related]
44. Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
Yang XJ; Sugimura J; Tretiakova MS; Furge K; Zagaja G; Sokoloff M; Pins M; Bergan R; Grignon DJ; Stadler WM; Vogelzang NJ; Teh BT
Cancer; 2004 Mar; 100(5):976-85. PubMed ID: 14983493
[TBL] [Abstract][Full Text] [Related]
45. Renal medullary carcinomas depend upon
Hong AL; Tseng YY; Wala JA; Kim WJ; Kynnap BD; Doshi MB; Kugener G; Sandoval GJ; Howard TP; Li J; Yang X; Tillgren M; Ghandi M; Sayeed A; Deasy R; Ward A; McSteen B; Labella KM; Keskula P; Tracy A; Connor C; Clinton CM; Church AJ; Crompton BD; Janeway KA; Van Hare B; Sandak D; Gjoerup O; Bandopadhayay P; Clemons PA; Schreiber SL; Root DE; Gokhale PC; Chi SN; Mullen EA; Roberts CW; Kadoch C; Beroukhim R; Ligon KL; Boehm JS; Hahn WC
Elife; 2019 Mar; 8():. PubMed ID: 30860482
[TBL] [Abstract][Full Text] [Related]
46. Renal medullary carcinoma: an aggressive neoplasm in patients with sickle cell trait.
Pickhardt PJ
Abdom Imaging; 1998; 23(5):531-2. PubMed ID: 9841069
[TBL] [Abstract][Full Text] [Related]
47. Renal medullary carcinoma: a case report and brief review of the literature.
Shetty A; Matrana MR
Ochsner J; 2014; 14(2):270-5. PubMed ID: 24940141
[TBL] [Abstract][Full Text] [Related]
48. Pathologic quiz case: gross hematuria in a 20-year-old black woman with sickle cell trait. Renal medullary carcinoma.
Hoenig JD; Husain AN; Waters BW
Arch Pathol Lab Med; 2002 May; 126(5):627-9. PubMed ID: 12013017
[No Abstract] [Full Text] [Related]
49. Renal medullary carcinoma associated with sickle cell trait: radiologic findings.
Davidson AJ; Choyke PL; Hartman DS; Davis CJ
Radiology; 1995 Apr; 195(1):83-5. PubMed ID: 7892499
[TBL] [Abstract][Full Text] [Related]
50. [Renal medullary carcinoma, a new clinico-pathological entity. Immunohistochemical, ultrastructural, flow cytometric and cytogenetic study of a case].
Chatelain D; de Pinieux G; Slama J; Couturier J; Le Charpentier M; Vielh P; Thirouard D; Vieillefond A
Ann Pathol; 1999 Sep; 19(4):320-4. PubMed ID: 10544769
[TBL] [Abstract][Full Text] [Related]
51. Renal medullary carcinoma and sickle cell trait.
Friedrichs P; Lassen P; Canby E; Graham C
J Urol; 1997 Apr; 157(4):1349. PubMed ID: 9120938
[No Abstract] [Full Text] [Related]
52. SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.
Vokshi BH; Davidson G; Tawanaie Pour Sedehi N; Helleux A; Rippinger M; Haller AR; Gantzer J; Thouvenin J; Baltzinger P; Bouarich R; Manriquez V; Zaidi S; Rao P; Msaouel P; Su X; Lang H; Tricard T; Lindner V; Surdez D; Kurtz JE; Bourdeaut F; Tannir NM; Davidson I; Malouf GG
Nat Commun; 2023 May; 14(1):3034. PubMed ID: 37236926
[TBL] [Abstract][Full Text] [Related]
53. [Renal medullary carcinoma in a young white adult without sickle cell trait or disease].
Mast Vilaseca R; Pons Escoda A
Radiologia; 2015; 57(4):361-3. PubMed ID: 25555478
[No Abstract] [Full Text] [Related]
54. Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies.
Shapiro DD; Soeung M; Perelli L; Dondossola E; Surasi DS; Tripathi DN; Bertocchio JP; Carbone F; Starbuck MW; Van Alstine ML; Rao P; Katz MHG; Parker NH; Shah AY; Carugo A; Heffernan TP; Schadler KL; Logothetis C; Walker CL; Wood CG; Karam JA; Draetta GF; Tannir NM; Genovese G; Msaouel P
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885132
[TBL] [Abstract][Full Text] [Related]
55. Renal medullary carcinoma: CT and MRI features.
Blitman NM; Berkenblit RG; Rozenblit AM; Levin TL
AJR Am J Roentgenol; 2005 Jul; 185(1):268-72. PubMed ID: 15972435
[TBL] [Abstract][Full Text] [Related]
56. Is renal medullary carcinoma the seventh nephropathy in sickle cell disease? A multi-center Nigerian survey.
Anazoeze M; Najibah G; Garba U; Shehu A; Florence F; Abdulaziz H; Marcus I; Oluwaseun A; Theresa N; Obike I; Sunday O; Ifeoma E; Anthony I; Barth C; Chide O; Joseph O; Malachy I; Kaladada K; Uche A; Kingsley A; Charles N; Angela U; Augustin D; Chikwudi A; Alozie E; Uchenna O; Caroline O; Obineche A; Iheanyi O
Afr Health Sci; 2016 Jun; 16(2):490-6. PubMed ID: 27605964
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic challenges of renal medullary carcinoma and the role for cytologic assessment: Case report and literature review.
Severseike BO; Schafernak KT; Willard SD; Goncalves LF; Kothari AK; Eshun FK; Mangum R
J Clin Lab Anal; 2023 Apr; 37(4):e24854. PubMed ID: 36843202
[TBL] [Abstract][Full Text] [Related]
58. A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma.
Msaouel P; Tannir NM; Walker CL
Clin Cancer Res; 2018 May; 24(9):2044-2049. PubMed ID: 29440190
[TBL] [Abstract][Full Text] [Related]
59. Re: Renal medullary carcinoma and its association with sickle cell trait: a case report and literature review.
Riminucci M; Corsi A
Curr Oncol; 2020 Jun; 27(3):e348. PubMed ID: 32669945
[No Abstract] [Full Text] [Related]
60. Renal Medullary Carcinoma Associated with Sickle Cell Trait.
Frazier AA
Radiographics; 2017; 37(5):1537. PubMed ID: 28898179
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
